臺北榮民總醫院

:::

李沛璋 (Pei-Chang Lee)

掛號

[簡介]

學歷
經歷
現職：
- - 迄今臺北榮民總醫院內科部胃腸肝膽科主治醫師
- - 迄今國立陽明大學醫學系助理教授
經歷：
- - 員山榮民醫院內科部主治醫師
- - 台北榮民總醫院胃腸肝膽科總住院醫師
- - 台北榮民總醫院內科部住院醫師
醫療專長
1. 肝硬化、肝癌、壺腹及十二指腸癌、膽胰疾病、臨床營養學。
證照

內科專科醫師消化專科醫師內視鏡專科腸道暨靜脈營養專科醫師
語言專長

中文英文台語

[著作]

1. Lee PC, Wu CJ, Hung YW, Lee CJ, Chi CT, Lee IC, Kuo YL, Chou SH, Luo JC, Hou MC, Huang YH. Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2022 Jun; 10(6):e004779.
2. Lee PC, Hsieh YC, Huo TI, Yang UC, Lin CH, Li CP, Huang YH, Hou MC, Lin HC, Lee KC. Active Vitamin D3 Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats. Mol Nutr Food Res. 2021 Feb;65(3):e2000937.
3. Lee PC, Chang TE, Wang YP, Lee KC, Lin YT, Chiou JJ, Huang CW, Yang UC, Li FY, Huang HC, Wu CY, Huang YH, Hou MC. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. J Formos Med Assoc. 2021 Nov 23;S0929-6646(21)00498-8.
4. Lee PC, Chao Y, Chen MH, Lan KH, Lee IC, Hou MC, Huang YH. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2020 Aug;8(2):e001072.
5. Lee PC, Chao Y, Chen MH, Lan KH, Lee CJ, Lee IC, Chen SC, Hou MC, Huang YH. Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. Cancers (Basel). 2020 Jan 11;12(1).